Bennet: Progress made on pharmaceutical-drug track-and-trace bill

“The track-and-trace draft proposal is the result of continued, bipartisan, good-faith discussions among a variety of participants,” Bennet said in a statement Wednesday. “While we still have work to do, I am pleased with this progress and believe if we keep working together we can get this done.”

ADVERTISEMENT
The bill would establish a more effective alert system for when a drug is found to be faulty, fraudulent or harmful, preventing more sickness or death from tainted pharmaceuticals.

“Families in Colorado shouldn’t have to worry that the medicine they take when they’re sick will make them sicker — or even worse,” Bennet said. “We can help by establishing a uniform, national drug traceability system that improves the security and safety of our drug supply chain for consumers.”

The bill would give the Food and Drug Administration (FDA) authority to work with drug distributors and manufacturers to develop a drug tracking and tracing system.

Although the bill isn’t finished, Bennet said he looks forward to getting it done soon.

“I look forward to continuing this bipartisan and bicameral work with members of the Senate HELP Committee and House Energy and Commerce Committee under the leadership of Chairman [Tom] Harkin [D-Iowa], ranking member [Mike] Enzi [R-Wyo.], Chairman [Fred] Upton [R-Mich.] and ranking member [Henry] Waxman [D-Calif.], and particularly with Sen. [Richard] Burr [R-N.C.], who has been a champion of this issue, as well as with the full range of stakeholders, including the FDA, to find consensus on this critically important and complex issue.”

Bennet serves on the Senate HELP Committee.